ACUR
Acura Pharmaceuticals
ACUR
ACUR
Delisted
ACUR was delisted on the 22nd of February, 2017.
22 hedge funds and large institutions have $11.1M invested in Acura Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
Holders
22
Holding in Top 10
1
Calls
$46K
Puts
$14K
Top Buyers
| 1 | +$15K | |
| 2 | +$3K | |
| 3 | +$1K | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$910 |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$272 |
Top Sellers
| 1 | -$223K | |
| 2 | -$68K | |
| 3 | -$39K | |
| 4 |
Walleye Trading
New York
|
-$4.36K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$649 |